Your 2025 OSA Pre-Op Protocol Is Already Obsolete

The Case That Shows Why OSA Screening Has to Change

Consider a scenario that plays out in ambulatory ORs far more often than anyone wants to admit. A 54-year-old woman, BMI 38, presenting to an ASC for an abdominoplasty with liposuction — a $17,000 cash-pay cosmetic procedure. No formal OSA diagnosis. She snored, her husband said, but 'everyone snores.' Standard pre-op labs, H&P cleared by the surgeon, nothing flagged. Induction proceeds — and within 90 seconds of direct laryngoscopy the team is looking at a Cormack-Lehane grade III view and an oxygen saturation trending to 88% in a patient who was supposed to be straightforward.

The team manages it — videolaryngoscopy, bougie, secured airway. But run that patient's STOP-Bang score retrospectively and she was a 5. Intermediate-to-high risk. Loud snoring, observed apneas, tired during the day, hypertension, BMI over 35, age over 50, female neck circumference borderline. The information was all there. There was simply no systematic process to surface it before she was already under.

That's not a documentation problem. That's a workflow problem. And it's happening in ASCs across the country, every single day. The patients are getting heavier, the procedures are moving out of hospitals and into ambulatory centers, and the guidelines we're using to screen these patients haven't been meaningfully updated since 2014 and 2016.

The Guideline Gap Is Real — and Getting Wider

A peer-reviewed narrative review published in August 2025 in Expert Review of Respiratory Medicine put a sharp point on something many of us have been feeling clinically for years: the existing ASA (2014) and SASM (2016) perioperative OSA guidelines are increasingly misaligned with the reality of ambulatory surgical practice. The authors argue explicitly that these frameworks weren't designed for the growing cohort of obese, higher-acuity OSA patients who are now routinely presenting to ASCs for same-day discharge procedures. You can read the full open-access text here: "The perioperative implications of the patient with Obstructive Sleep Apnea — a narrative review," PMC12320865 (2025).

The good news — if you want to call it that — is that SASM knows this. According to an article published by the Anesthesia Patient Safety Foundation (APSF, 2024), SASM's collaborative task force is actively developing new perioperative OSA recommendations covering risk stratification, postoperative analgesia, monitoring standards, and discharge considerations — with ambulatory surgery patients specifically identified as a critical gap population. New guidelines are coming. The question is what you do in the window between now and when they drop.

The answer is not to wait. Because your patients aren't waiting. They're booking procedures and showing up to your ASC today.

STOP-Bang Is Your Best Tool — and It Has a Real Limitation You Need to Understand

SAMBA (the Society for Ambulatory Anesthesia) recommends STOP-Bang as the preferred OSA screening tool in the ASC setting, and for good reason. A systematic review and meta-analysis (PMC9710034, 2022) pooling 10 studies and over 3,200 surgical patients established that STOP-Bang achieves a pooled sensitivity of 88% for moderate-to-severe OSA and 90% for severe OSA. For a screening tool, that sensitivity is excellent. You're catching 9 out of 10 patients with severe disease.

But here's the number that should give ASC administrators pause: pooled specificity for moderate-to-severe OSA is only 29%. That means for every patient you correctly flag as high-risk, you're generating a large volume of false positives — patients who score intermediate-to-high on STOP-Bang but don't actually have clinically significant OSA. In a high-volume cosmetic or GI ASC running 15 to 20 cases per day, that false-positive burden creates real operational drag. You're either delaying cases for further workup or — and this is the dangerous option — you're starting to treat the tool as noise and ignoring elevated scores because 'everyone scores a 3 or 4.'

The 2025 narrative review in Expert Review of Respiratory Medicine addresses this directly, noting that even with validated STOP-Bang screening, many cases of symptomatic OSA still go undetected preoperatively — and calls for supplemental diagnostic measures such as overnight oximetry to close that gap. In practical terms, this means a STOP-Bang score alone is a starting point, not a complete assessment. For patients in that intermediate zone (score 3–4), especially those with a BMI over 35, poorly controlled hypertension, or a history of GERD, supplemental data changes the clinical picture.

OSA, PONV, and Your Multimodal Analgesia Protocol

Here's a connection that most ASC protocols haven't incorporated yet, and it matters particularly for laparoscopic and cosmetic cases: OSA risk independently predicts PONV. A prospective cohort study published in 2025 (PMC12831034) followed 200 laparoscopic surgical patients from January through July 2025 and found a statistically significant association between STOP-Bang-defined OSA risk and postoperative nausea and vomiting. Notably, female patients in the cohort scored significantly higher on both STOP-Bang and the Apfel scale — a finding that reinforces why you can't treat these two risk assessments as separate silos.

Think about what this means operationally. If you're running a multimodal analgesia protocol — and you should be, especially in an opioid-minimization framework — your PONV prophylaxis decisions and your OSA management decisions are informing each other. A patient with a STOP-Bang score of 5 presenting for laparoscopic sleeve gastrectomy or a robotic-assisted procedure isn't just a difficult-airway flag. She's a high-probability PONV patient who needs aggressive prophylaxis: ondansetron 4mg IV, dexamethasone 8mg at induction, scopolamine patch placed preoperatively, and a total intravenous anesthesia (TIVA) approach with propofol rather than volatile agents when feasible. These decisions should be pre-populated in your anesthetic plan before the patient walks through the door — not improvised in the PACU when she's already retching.

This is exactly the kind of integrated, pre-populated clinical decision support that VeriOp.ai was built to deliver. When STOP-Bang scores are collected digitally before the day of surgery, they don't just exist as a number on a form — they can trigger structured anesthetic planning flags that your CRNA or anesthesiologist reviews before induction. That's the difference between reactive management and protocol-driven care.

The Airway Risk You Can't Outsource to the Surgeon

One point sometimes gets soft-pedaled in these discussions and deserves to be said plainly: OSA patients have anatomically difficult airways, and in an ASC you don't have the same rapid-rescue infrastructure that exists in a hospital setting. The 2025 Expert Review of Respiratory Medicine narrative review documents that intermediate-to-high STOP-Bang scores correlate with higher rates of difficult intubation, intraoperative desaturation, and unplanned ICU admission. Upper airway anatomy in OSA — the redundant soft tissue, the retrognathia, the increased Mallampati classification — doesn't disappear just because your case is listed as 'low complexity.'

A defensible protocol: any patient with a STOP-Bang of 4 or higher automatically triggers a structured airway assessment addendum in the pre-op record. Mallampati class, thyromental distance, neck circumference, mouth opening, cervical range of motion — documented, not assumed. Videolaryngoscopy is staged at the head of the bed before induction, not retrieved from a supply room after I already have a problem. A supraglottic airway device as a rescue plan is confirmed available. This takes approximately four additional minutes of setup. Four minutes of preparation versus a potential cannot-intubate-cannot-oxygenate scenario in a freestanding ASC with no in-house surgical airway backup. The math is obvious.

A 2025 systematic review (PMC12576096) examining 11 studies and over 5,700 OSA patients evaluated the safety of upper airway surgery in ASCs specifically, looking at unplanned admission rates and 24-hour complications to define safe ASC candidacy criteria. The takeaway isn't that OSA patients can't have ambulatory surgery — they absolutely can, and restricting all OSA patients from ASC procedures would be both clinically unsupported and financially catastrophic for your practice. The takeaway is that candidacy determination has to be systematic, documented, and done before the day of surgery.

CPAP Adherence: The Variable That Changes Everything

Not all OSA patients are the same perioperative risk, and your protocols should reflect that. The 2025 narrative review is clear on this point: ambulatory surgery is not contraindicated in OSA patients with optimized comorbidities and documented CPAP adherence. Studies show no significant difference in postoperative respiratory events between OSA and non-OSA patients when care is well-coordinated. The operative word is 'documented.'

Asking a patient 'do you use your CPAP?' in the holding area on the morning of surgery is nearly useless. You get socially desirable answers. What you want is objective data — ideally a CPAP compliance download from the device itself showing average nightly usage hours over the prior 30 days, or at minimum a documented conversation with the patient's sleep medicine provider prior to the procedure date. A patient using CPAP at 6+ hours per night with a residual AHI below 5 is a categorically different perioperative risk than a patient whose machine sits on the nightstand collecting dust.

Build CPAP compliance verification into your pre-op questionnaire. Not as a free-text field where the patient writes 'yes' — as a structured checklist that captures device type, prescribed pressure or APAP range, average nightly usage, and whether the patient is bringing their device to the ASC for postoperative recovery. This data should be collected days before surgery, not hours before. VeriOp.ai's digital pre-op platform is designed to meet criteria for Clinical Decision Support under the 21st Century Cures Act, and structured OSA and CPAP data collection is built into the intake workflow so your clinical team has actionable information in the chart before you ever shake hands with the patient.

What Your ASC Should Do Right Now — Before New Guidelines Drop

Don't wait for SASM's updated guidelines before making changes. By the time those guidelines are finalized, published, disseminated, and incorporated into your ASC's policy manual, another eighteen months will have passed and you'll have seen hundreds more unscreened OSA patients. Here's what a clinically defensible 2025 protocol looks like in a private ambulatory setting:

• Deploy STOP-Bang digitally, pre-visit. Not on a clipboard in the waiting room. Patients should complete STOP-Bang as part of a structured digital pre-op intake 5–10 days before surgery. This gives you time to act on elevated scores.
• Add supplemental screening for intermediate scores. A STOP-Bang of 3–4 in a patient with BMI >35 or uncontrolled hypertension should trigger a request for overnight oximetry results or a sleep medicine consult note. Don't rely on the questionnaire alone.
• Integrate STOP-Bang scores into your PONV risk stratification. Patients flagged as OSA risk should have Apfel scoring explicitly documented and PONV prophylaxis pre-planned — ondansetron, dexamethasone, TIVA consideration — before the day of surgery.
• Require documented CPAP compliance for known OSA patients. Device download or sleep medicine provider letter, not self-report. Set this expectation at scheduling.
• Standardize your airway preparation protocol for high STOP-Bang scores. Videolaryngoscopy staged, supraglottic rescue device confirmed, extended pre-oxygenation planned. Four minutes of setup. Non-negotiable.
• Document your candidacy determination. When you've assessed an OSA patient and determined they are appropriate for same-day ambulatory discharge, that clinical reasoning needs to be in the record — not implied, not assumed.

For the plastic surgeons and ASC administrators reading this: a single unplanned hospital transfer on a $20,000 cash-pay cosmetic case doesn't just cost you the revenue from that case. It costs you the patient's trust, the referral network word-of-mouth, and potentially your ASC's accreditation standing if it becomes a pattern. The upfront investment in systematic pre-op OSA screening is not a clinical nicety — it's a business protection strategy.

If you want to see how VeriOp.ai structures these workflows in practice — including STOP-Bang integration, PONV risk flagging, and airway assessment prompts — you can review our validation study for the clinical evidence behind the platform design.